文献速递妇科

GPX3支持卵巢癌体内肿瘤进展并促进GDF15表达

GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15.
PubMed 文献 · Gynecol Oncol · 2024-02-10

在ID8卵巢癌细胞中敲低GPX3可消除克隆形成能力和腹腔内肿瘤建立,且效应依赖于敲低程度;RNA测序显示GPX3缺失降低促肿瘤信号通路相关基因表达,并鉴定GDF15为强依赖GPX3的介质。GPX3表达与调节性T细胞、巨噬细胞浸润等促肿瘤免疫特征及PD-L1表达显著相关,提示GPX3可能是对免疫检查点抑制剂敏感的卵巢肿瘤的替代标志物。

要点

  • GPX3敲低可消除ID8卵巢癌细胞的克隆形成能力和腹腔内肿瘤建立,且效应依赖于敲低程度。
  • GPX3缺失降低促肿瘤信号通路相关基因表达,GDF15表达强依赖GPX3。
  • GPX3表达与调节性T细胞、巨噬细胞浸润及PD-L1表达显著相关。

核心结论

  • 首次证明肿瘤产生的GPX3是卵巢癌体内生长所必需,且其调节GDF15表达。
  • 浆液性卵巢肿瘤中GPX3表达相关的免疫特征提示GPX3可能是对免疫检查点抑制剂敏感的卵巢肿瘤的替代标志物。

研究设计与样本

  • 在ID8卵巢癌细胞中用shRNA敲低GPX3,采用同系腹腔内异种移植模型测试GPX3在肿瘤建立中的作用。
  • 在OVCAR3细胞中shRNA介导GPX3敲低后进行RNA测序分析,以鉴定GPX3依赖的基因表达特征。

主要发现

  • GPX3敲低消除了克隆形成能力和体内腹腔内肿瘤发展,且效应依赖于GPX3敲低水平。
  • RNA测序显示GPX3缺失导致与促肿瘤信号通路相关的基因表达模式降低。
  • 验证研究鉴定GDF15为强依赖GPX3的基因,GDF15是TGF-β生长因子家族成员,具有已知的致癌和免疫调节活性。
  • GPX3表达与促肿瘤免疫细胞特征(包括调节性T细胞和巨噬细胞浸润)正相关,并与PD-L1表达显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We previously reported that high expression of the extracellular glutathione peroxidase GPX3 is associated with poor patient outcome in ovarian serous adenocarcinomas, and that GPX3 protects ovarian cancer cells from oxidative stress in culture. Here we tested if GPX3 is necessary for tumor establishment in vivo and to identify novel downstream mediators of GPX3's pro-tumorigenic function. METHODS: GPX3 was knocked-down in ID8 ovarian cancer cells by shRNA to test the role of GPX3 in tumor establishment using a syngeneic IP xenograft model. RNA sequencing analysis was carried out in OVCAR3 cells following shRNA-mediated GPX3 knock-down to identify GPX3-dependent gene expression signatures. RESULTS: GPX3 knock-down abrogated clonogenicity and intraperitoneal tumor development in vivo, and the effects were dependent on the level of GPX3 knock-down. RNA sequencing showed that loss of GPX3 leads to decreased gene expression patterns related to pro-tumorigenic signaling pathways. Validation studies identified GDF15 as strongly dependent on GPX3. GDF15, a member of the TGF-β growth factor family, has known oncogenic and immune modulatory activities. Similarly, GPX3 expression positively correlated with pro-tumor immune cell signatures, including regulatory T-cell and macrophage infiltration, and displayed significant correlation with PD-L1 expression. CONCLUSIONS: We show for the first time that tumor produced GPX3 is necessary for ovarian cancer growth in vivo and that it regulates expression of GDF15. The immune profile associated with GPX3 expression in serous ovarian tumors suggests that GPX3 may be an alternate marker of ovarian tumors susceptible to immune check-point inhibitors.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Chang C, Cheng YY, Kamlapurkar S, et al. GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15. Gynecol Oncol. 2024. PMID: 38342006. doi:10.1016/j.ygyno.2024.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。